Benzbromarone (BioDeep_00000017954)
human metabolite Chemicals and Drugs
代谢物信息卡片
(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone
化学式: C17H12Br2O3 (421.9153122)
中文名称: 苯溴马隆
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=CC=CC=C2O1
InChI: InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3
描述信息
Benzbromarone (INN) is a uricosuric agent used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. It is structurally related to the antiarrhythmic amiodarone. Benzbromarone is a very potent inhibitor of CYP2C9. Several analogues of the drug have been developed as CYP2C9 and CYP2C19 inhibitors for use in research.
M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents
C26170 - Protective Agent > C921 - Uricosuric Agent
同义名列表
35 个代谢物同义名
(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone; Ketone, 3,5-dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl; 3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone; 2,6-dibromo-4-(2-ethyl-1-benzofuran-3-carbonyl)phenol; 2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran; Sanofi winthrop brand OF benzbromarone; Ratiopharm brand OF benzbromarone; Benzbromarone ratiopharm brand; Heumann brand OF benzbromarone; Sanfer brand OF benzbromarone; Aliud brand OF benzbromarone; Benzbromarone heumann brand; Benzbromarone sanfer brand; Benzbromarone aliud brand; Benzbromaron-ratiopharm; Benzbromaron ratiopharm; Benzbromaronratiopharm; Benzbromarone(usan); AL, benzbromaron; Benzbromaron al; benzbromarone; Benzbromaron; L 2214-Labaz; Narcaricin; Acifugan; Uricovac; Normurat; Besuric; Urinorm; Minuric; Hipurik; Uroleap; Desuric; Exurate
数据库引用编号
10 个数据库交叉引用编号
- ChEBI: CHEBI:3023
- PubChem: 2333
- HMDB: HMDB0041834
- DrugBank: DB12319
- ChEMBL: CHEMBL388590
- Wikipedia: Benzbromarone
- MeSH: Benzbromarone
- chemspider: 2243
- CAS: 3562-84-3
- PMhub: MS000001416
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- C-Q Yan, C Liang, Z-R Lan, C Su, S-Y Xiong, Y-X Yang, J-M Chen, S-L Tang, J-S Huang, Z-H Zhang, M-J Luo, Z-H Xiao. Comparison of the efficacy of febuxostat vs. benzbromarone in the treatment of gout: a meta-analysis in Chinese gout patients.
European review for medical and pharmacological sciences.
2023 Dec; 27(24):11988-12003. doi:
10.26355/eurrev_202312_34797. [PMID: 38164861] - Yanfen Niu, Qiang Li, Caixia Tu, Na Li, Lihui Gao, Hua Lin, Zhenyu Wang, Zhihong Zhou, Ling Li. Hypouricemic Actions of the Pericarp of Mangosteen in Vitro and in Vivo.
Journal of natural products.
2023 01; 86(1):24-33. doi:
10.1021/acs.jnatprod.2c00531. [PMID: 36634312] - Yu-Kai Zhang, Jia-Shu Chen, Min-Min Wang, Chuan-Zeng Wang, Mu-Xuan Wang, Zhen Wang, Qin-Liang Yang, Bin Sun, Jin-Yue Sun, Yu-Fa Liu, Chao Liu. Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effects.
Bioorganic chemistry.
2022 09; 126(?):105916. doi:
10.1016/j.bioorg.2022.105916. [PMID: 35687986] - Xizi Liu, Shiyi Han, Qian Yang, Siyang Fan. Beneficial herb-drug interaction of Gnaphalium affine extract on benzbromarone: A pharmacokinetic and pharmacodynamic study in rats.
Phytomedicine : international journal of phytotherapy and phytopharmacology.
2022 Jul; 102(?):154203. doi:
10.1016/j.phymed.2022.154203. [PMID: 35660349] - Dongmei Liu, Binbin Zhou, Zhen Li, Zhuojun Zhang, Xiaojuan Dai, Zongfei Ji, Huiyong Chen, Ying Sun, Lindi Jiang. Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study.
Clinical rheumatology.
2022 Jul; 41(7):2121-2128. doi:
10.1007/s10067-022-06110-5. [PMID: 35229198] - Somdutt Mujwar, Avanish Tripathi. Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans.
Journal of molecular modeling.
2022 Jun; 28(7):193. doi:
10.1007/s00894-022-05185-w. [PMID: 35716240] - Danii L S Suijk, Michaël J B van Baar, Erik J M van Bommel, Zainab Iqbal, Merle M Krebber, Volker Vallon, Daan Touw, Ewout J Hoorn, Max Nieuwdorp, Mark M H Kramer, Jaap A Joles, Petter Bjornstad, Daniël H van Raalte. SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function.
Clinical journal of the American Society of Nephrology : CJASN.
2022 05; 17(5):663-671. doi:
10.2215/cjn.11480821. [PMID: 35322793] - Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials.
International journal of clinical pharmacology and therapeutics.
2022 Mar; 60(3):159-166. doi:
10.5414/cp204097. [PMID: 34779393] - Xiaomei Xue, Zhen Liu, Xinde Li, Jie Lu, Can Wang, Xuefeng Wang, Wei Ren, Ruixia Sun, Zhaotong Jia, Xiaopeng Ji, Ying Chen, Yuwei He, Aichang Ji, Wenyan Sun, Hui Zhang, Tony R Merriman, Changgui Li, Lingling Cui. The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study.
Rheumatology (Oxford, England).
2021 06; 60(6):2661-2671. doi:
10.1093/rheumatology/keaa668. [PMID: 33211886] - Junichiro Uda, Seiichi Kobashi, Naoki Ashizawa, Koji Matsumoto, Takashi Iwanaga. Novel monocyclic amide-linked phenol derivatives without mitochondrial toxicity have potent uric acid-lowering activity.
Bioorganic & medicinal chemistry letters.
2021 05; 40(?):127900. doi:
10.1016/j.bmcl.2021.127900. [PMID: 33684442] - Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Hebatallah M Essam, Heba M Mohamed. Developing, optimizing, and assessing a green electrophoretic method for determination of benzbromarone and allopurinol with its active metabolite in biological and pharmaceutical matrices.
Journal of separation science.
2021 Apr; 44(7):1461-1470. doi:
10.1002/jssc.202000934. [PMID: 33527723] - Keishi Yamasaki, Akito Kawai, Keiki Sakurama, Nagiko Udo, Yuta Yoshino, Yuki Saito, Kenji Tsukigawa, Koji Nishi, Masaki Otagiri. Interaction of Benzbromarone with Subdomains IIIA and IB/IIA on Human Serum Albumin as the Primary and Secondary Binding Regions.
Molecular pharmaceutics.
2021 03; 18(3):1061-1070. doi:
10.1021/acs.molpharmaceut.0c01004. [PMID: 33478218] - Jun Xia Zhang, Xue Lin, Jinxiu Xu, Feng Tang. Hyperuricemia Inhibition Protects SD Rats Against Fructose-Induced Obesity Hypertension Via Modulation of Inflammation and Renin-Angiotensin System in Adipose Tissue.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
2021 Mar; 129(4):314-321. doi:
10.1055/a-1023-6710. [PMID: 31683330] - Dingyu Wang, Li Sun, Guowei Zhang, Yang Liu, Zhaoguang Liang, Jing Zhao, Shuangli Yin, Mengqi Su, Song Zhang, Ying Wei, He Liu, Desen Liang, Yue Li. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
Cardiovascular toxicology.
2021 03; 21(3):192-205. doi:
10.1007/s12012-020-09611-4. [PMID: 33099748] - Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Bushra Mdkhana, Saba Al Heialy, Elaref Ratemi, Malak Alghamdi, Salah Abusnana, Tarek Kashour, Qutayba Hamid, Rabih Halwani. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
Archives of toxicology.
2020 12; 94(12):4037-4041. doi:
10.1007/s00204-020-02869-1. [PMID: 32808185] - Tong Zhao, Qing Meng, Zhuosen Sun, Yanyu Chen, Wei Ai, Zean Zhao, Dongwei Kang, Yue Dong, Ruipeng Liang, Ting Wu, Jianxin Pang, Xinyong Liu, Peng Zhan. Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability.
Journal of medicinal chemistry.
2020 10; 63(19):10829-10854. doi:
10.1021/acs.jmedchem.0c00223. [PMID: 32897699] - Ines Cabrita, Andre Kraus, Julia Katharina Scholz, Kathrin Skoczynski, Rainer Schreiber, Karl Kunzelmann, Björn Buchholz. Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo.
Nature communications.
2020 08; 11(1):4320. doi:
10.1038/s41467-020-18104-5. [PMID: 32859916] - Luisa Möhle, Barbora Schwarzová, Markus Krohn, Sven Marcel Stefan, Jens Pahnke. Using a qPCR device to screen for modulators of ABC transporter activity: A step-by-step protocol.
Journal of pharmacological and toxicological methods.
2020 Jul; 104(?):106882. doi:
10.1016/j.vascn.2020.106882. [PMID: 32474136] - Christopher L Gardner, Danilo R da Silva, Fernando A Pagliai, Lei Pan, Kaylie A Padgett-Pagliai, Ryan A Blaustein, Marcelo L Merli, Dan Zhang, Cécile Pereira, Max Teplitski, Jose X Chaparro, Svetlana Y Folimonova, Ana Conesa, Salvador Gezan, Graciela L Lorca, Claudio F Gonzalez. Assessment of unconventional antimicrobial compounds for the control of 'Candidatus Liberibacter asiaticus', the causative agent of citrus greening disease.
Scientific reports.
2020 03; 10(1):5395. doi:
10.1038/s41598-020-62246-x. [PMID: 32214166] - Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, Masahiko Fushimi, Tetsuo Ohashi. Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study.
Clinical and experimental nephrology.
2020 Mar; 24(Suppl 1):62-70. doi:
10.1007/s10157-020-01849-0. [PMID: 31980978] - Yoshitaka Kimura, Tamiko Yanagida, Akiko Onda, Daisuke Tsukui, Makoto Hosoyamada, Hajime Kono. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation.
Arteriosclerosis, thrombosis, and vascular biology.
2020 03; 40(3):570-582. doi:
10.1161/atvbaha.119.313224. [PMID: 31996020] - Satoru Kuriyama. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
Clinical and experimental nephrology.
2020 Mar; 24(Suppl 1):1-5. doi:
10.1007/s10157-019-01811-9. [PMID: 31754883] - Esraa Abdel-Nassir Abdel-Razek, Amira M Abo-Youssef, Amany A Azouz. Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression.
Life sciences.
2020 Feb; 243(?):117272. doi:
10.1016/j.lfs.2020.117272. [PMID: 31926251] - Hanna Ellmann, Sara Bayat, Elizabeth Araujo, Bernhard Manger, Arnd Kleyer, Alexander Cavallaro, Michael Lell, Hannah Schenker, David Simon, Koray Tascilar, Herbert S B Baraf, Georg Schett, Jürgen Rech. Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Arthritis & rheumatology (Hoboken, N.J.).
2020 01; 72(1):150-156. doi:
10.1002/art.41063. [PMID: 31353871] - Leonardo Santos Hoff, Claudia Goldenstein-Schainberg, Ricardo Fuller. Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
Advances in rheumatology (London, England).
2019 12; 60(1):2. doi:
10.1186/s42358-019-0106-4. [PMID: 31892344] - Xuechen Li, Zhenxin Yan, Jinying Tian, Xiaolin Zhang, Huirong Han, Fei Ye. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Annals of clinical and laboratory science.
2019 Nov; 49(6):756-762. doi:
NULL. [PMID: 31882426] - Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Molecular pharmacology.
2019 11; 96(5):629-640. doi:
10.1124/mol.119.115964. [PMID: 31515284] - Ting-Ting Chung, Kuang-Hui Yu, Chang-Fu Kuo, Shue-Fen Luo, Meng-Jiun Chiou, Wen-Ching Lan, Jung-Sheng Chen, Wen-Yi Tseng, Ao-Ho Hsieh, Lian-Chin Wang. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.
Arthritis research & therapy.
2019 09; 21(1):210. doi:
10.1186/s13075-019-1993-9. [PMID: 31533805] - Nan Liang, Mingshu Sun, Ruixia Sun, Ting Xu, Lingling Cui, Can Wang, Lidan Ma, Xiaoyu Cheng, Xiaomei Xue, Wenyan Sun, Xuan Yuan, Hui Zhang, Hailong Li, Yuwei He, Aichang Ji, Xinjiang Wu, Changgui Li. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
Arthritis research & therapy.
2019 09; 21(1):200. doi:
10.1186/s13075-019-1976-x. [PMID: 31477161] - Valderilio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas-Santos, Geraldo da Rocha Castelar Pinheiro, Eduardo Dos Santos Paiva. Benzbromarone in the treatment of gout.
Advances in rheumatology (London, England).
2019 08; 59(1):37. doi:
10.1186/s42358-019-0080-x. [PMID: 31391099] - Jing Wu, Yu-Ping Zhang, Yuan Qu, Li-Gang Jie, Jia-Xin Deng, Qing-Hong Yu. Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients.
International journal of rheumatic diseases.
2019 Aug; 22(8):1445-1451. doi:
10.1111/1756-185x.13652. [PMID: 31317680] - Akinori Takemura, Simin Gong, Shuichi Sekine, Kousei Ito. Inhibition of biliary network reconstruction by benzbromarone delays recovery from pre-existing liver injury.
Toxicology.
2019 07; 423(?):32-41. doi:
10.1016/j.tox.2019.05.004. [PMID: 31102694] - Menaka C Thounaojam, Annalisa Montemari, Folami L Powell, Prerana Malla, Diana R Gutsaeva, Alessandra Bachettoni, Guido Ripandelli, Andrea Repossi, Amany Tawfik, Pamela M Martin, Francesco Facchiano, Manuela Bartoli. Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.
Diabetes.
2019 05; 68(5):1014-1025. doi:
10.2337/db18-0912. [PMID: 30728185] - Xiaolan Ye, Jian Wu, Kun Tang, Wenge Li, Cunquan Xiong, Li Zhuo. Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports.
Medicine.
2019 Apr; 98(15):e15214. doi:
10.1097/md.0000000000015214. [PMID: 30985721] - Xinrui Li, Jing Liu, Liang Ma, Ping Fu. Pharmacological urate-lowering approaches in chronic kidney disease.
European journal of medicinal chemistry.
2019 Mar; 166(?):186-196. doi:
10.1016/j.ejmech.2019.01.043. [PMID: 30769179] - Haibo Yu, Xinying Liu, Yaxiang Song, Jiafen Cheng, Hui Bao, Ling Qin, Xuan Zhou, Ling Wang, Ai Peng. Safety and Efficacy of Benzbromarone and Febuxostat in Hyperuricemia Patients with Chronic Kidney Disease: A Prospective Pilot Study.
Clinical and experimental nephrology.
2018 Dec; 22(6):1324-1330. doi:
10.1007/s10157-018-1586-y. [PMID: 29761242] - Geofrey Sing'ombe Ombiro, Taku Sawai, Yoshiteru Noutoshi, Yuta Nishina, Hidenori Matsui, Mikihiro Yamamoto, Kazuhiro Toyoda, Yuki Ichinose. Specific growth inhibitors of Ralstonia solanacearum, Xanthomonas oryzae pv. oryzae, X. campestris pv. campestris, and Clavibacter michiganensis subsp. michiganensis.
Microbiological research.
2018 Oct; 215(?):29-35. doi:
10.1016/j.micres.2018.06.005. [PMID: 30172306] - Hsu-Wen Chou, Hsien-Tsai Chiu, Ching-Wei Tsai, I-Wen Ting, Hung-Chieh Yeh, Han-Chun Huang, Chin-Chi Kuo. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2018 09; 33(9):1620-1627. doi:
10.1093/ndt/gfx313. [PMID: 29165620] - Masanari Shiramoto, Sha Liu, Zancong Shen, Xiaohong Yan, Amy Yamamoto, Michael Gillen, Yasushi Ito, Jesse Hall. Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
Rheumatology (Oxford, England).
2018 09; 57(9):1602-1610. doi:
10.1093/rheumatology/key100. [PMID: 29868853] - Peng Sun, Jing-Jie Zhu, Ting Wang, Qi Huang, Yu-Ren Zhou, Bang-Wei Yu, Hua-Liang Jiang, He-Yao Wang. Benzbromarone aggravates hepatic steatosis in obese individuals.
Biochimica et biophysica acta. Molecular basis of disease.
2018 06; 1864(6 Pt A):2067-2077. doi:
10.1016/j.bbadis.2018.03.009. [PMID: 29526820] - Nanako Muraya, Daisuke Kadowaki, Shigeyuki Miyamura, Kenichiro Kitamura, Kohei Uchimura, Yuki Narita, Yohei Miyamoto, Victor Tuan Giam Chuang, Kazuaki Taguchi, Toru Maruyama, Masaki Otagiri, Sumio Hirata. Benzbromarone Attenuates Oxidative Stress in Angiotensin II- and Salt-Induced Hypertensive Model Rats.
Oxidative medicine and cellular longevity.
2018; 2018(?):7635274. doi:
10.1155/2018/7635274. [PMID: 29967665] - Hui Wang, Ying Peng, Tingjian Zhang, Qunsheng Lan, Huimin Zhao, Wenbao Wang, Yufei Zhao, Xu Wang, Jianxin Pang, Shaojie Wang, Jiang Zheng. Metabolic Epoxidation Is a Critical Step for the Development of Benzbromarone-Induced Hepatotoxicity.
Drug metabolism and disposition: the biological fate of chemicals.
2017 12; 45(12):1354-1363. doi:
10.1124/dmd.117.077818. [PMID: 29021351] - Mina Yoshida, Naoki Cho, Hidetaka Akita, Kaoru Kobayashi. Association of a reactive intermediate derived from 1',6-dihydroxy metabolite with benzbromarone-induced hepatotoxicity.
Journal of biochemical and molecular toxicology.
2017 Oct; 31(10):. doi:
10.1002/jbt.21946. [PMID: 28598529] - Hsiu-Chen Lin, Masao Daimon, Ching-Hung Wang, Yi Ho, Yow-Shieng Uang, Shuo-Ju Chiang, Li-Hsuan Wang. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
International journal of cardiology.
2017 Apr; 233(?):85-90. doi:
10.1016/j.ijcard.2017.02.013. [PMID: 28202260] - Yu Wang, Zhi-Jian Lin, An-Zheng Nie, Li-Yu Li, Bing Zhang. [Effect of Chinese herb chicory extract on expression of renal transporter Glut9 in rats with hyperuricemia].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
2017 Mar; 42(5):958-963. doi:
10.19540/j.cnki.cjcmm.2017.0029. [PMID: 28994541] - Lisa K Stamp. Major unanswered questions in the clinical gout field.
Current opinion in rheumatology.
2017 03; 29(2):171-177. doi:
10.1097/bor.0000000000000367. [PMID: 27926541] - Qiao Zhou, Jiang Su, Ting Zhou, Juan Tian, Xixi Chen, Jing Zhu. A study comparing the safety and efficacy of febuxostat, allopurinol, and benzbromarone in Chinese gout patients: a retrospective cohort study
.
International journal of clinical pharmacology and therapeutics.
2017 Feb; 55(2):163-168. doi:
10.5414/cp202629. [PMID: 27936522] - K Akioka, T Ishikawa, M Osaka, Y Kadotani, K Okugawa, K Nakano, Y Osaka, K Tsuchiya, H Sako. Hyperuricemia and Acute Renal Failure in Renal Transplant Recipients Treated With High-Dose Mizoribine.
Transplantation proceedings.
2017 Jan; 49(1):73-77. doi:
10.1016/j.transproceed.2016.11.015. [PMID: 28104163] - Sunao Kojima, Shinobu Kojima, Atsuko Hifumi, Hirofumi Soejima, Hisao Ogawa. Therapeutic strategy for efficient reduction of serum uric acid levels with allopurinol versus benzbromarone in hyperuricemic patients with essential hypertension - A randomized crossover study (terao study).
International journal of cardiology.
2016 Dec; 224(?):437-439. doi:
10.1016/j.ijcard.2016.09.073. [PMID: 27701062] - L K Stamp, J Haslett, C Frampton, D White, D Gardner, S Stebbings, G Taylor, R Grainger, R Kumar, S Kumar, T Kain, D Porter, M Corkill, A Cathro, S Metcalfe, J Wyeth, N Dalbeth. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Internal medicine journal.
2016 Sep; 46(9):1075-80. doi:
10.1111/imj.13173. [PMID: 27391386] - Gang Chen, Ping Jia. Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia.
Pharmacological reports : PR.
2016 Aug; 68(4):782-6. doi:
10.1016/j.pharep.2016.04.014. [PMID: 27258609] - Thomas A Baillie, Deepak Dalvie, Ivonne M C M Rietjens, S Cyrus Khojasteh. Biotransformation and bioactivation reactions - 2015 literature highlights.
Drug metabolism reviews.
2016 05; 48(2):113-38. doi:
10.1080/03602532.2016.1195404. [PMID: 27362326] - Kai Wang, Hui Wang, Ying Peng, Jiang Zheng. Identification of Epoxide-Derived Metabolite(s) of Benzbromarone.
Drug metabolism and disposition: the biological fate of chemicals.
2016 Apr; 44(4):607-15. doi:
10.1124/dmd.115.066803. [PMID: 26792818] - Sung Oh Ahn, Shuichi Ohtomo, Jumpei Kiyokawa, Toshito Nakagawa, Mizuki Yamane, Kyoung June Lee, Ki Hwan Kim, Byung Ho Kim, Jo Tanaka, Yoshiki Kawabe, Naoshi Horiba. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
The Journal of pharmacology and experimental therapeutics.
2016 Apr; 357(1):157-66. doi:
10.1124/jpet.115.231647. [PMID: 26907620] - Weifeng Xu, Yujie Huang, Lei Li, Zhen Sun, Yachen Shen, Jing Xing, Min Li, Dongming Su, Xiubin Liang. Hyperuricemia induces hypertension through activation of renal epithelial sodium channel (ENaC).
Metabolism: clinical and experimental.
2016 Mar; 65(3):73-83. doi:
10.1016/j.metabol.2015.10.026. [PMID: 26892518] - Lili Ma, Lei Wei, Huiyong Chen, Zhuojun Zhang, Qiang Yu, Zongfei Ji, Lindi Jiang. Influence of urate-lowering therapies on renal handling of uric acid.
Clinical rheumatology.
2016 Jan; 35(1):133-41. doi:
10.1007/s10067-014-2806-9. [PMID: 25373449] - Jianxing Zhao, Ying Huang. Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy.
Clinica chimica acta; international journal of clinical chemistry.
2015 Oct; 450(?):115-20. doi:
10.1016/j.cca.2015.08.005. [PMID: 26276048] - Takafumi Tomida, Hayao Okamura, Masahiro Satsukawa, Tsuyoshi Yokoi, Yoshihiro Konno. Multiparametric assay using HepaRG cells for predicting drug-induced liver injury.
Toxicology letters.
2015 Jul; 236(1):16-24. doi:
10.1016/j.toxlet.2015.04.014. [PMID: 25934330] - Serena Massari, Giulio Nannetti, Jenny Desantis, Giulia Muratore, Stefano Sabatini, Giuseppe Manfroni, Beatrice Mercorelli, Violetta Cecchetti, Giorgio Palù, Gabriele Cruciani, Arianna Loregian, Laura Goracci, Oriana Tabarrini. A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
Journal of medicinal chemistry.
2015 May; 58(9):3830-42. doi:
10.1021/acs.jmedchem.5b00012. [PMID: 25856229] - Punchong Hanvivadhanakul, Ratchapruk Wongdet. Outcome of Treatment in Gouty Arthritis Patients: A Retrospective Study.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
2015 Apr; 98 Suppl 3(?):S46-50. doi:
NULL. [PMID: 26387388] - Philip C Robinson, Nicola Dalbeth. Advances in pharmacotherapy for the treatment of gout.
Expert opinion on pharmacotherapy.
2015 Mar; 16(4):533-46. doi:
10.1517/14656566.2015.997213. [PMID: 25547991] - Daisuke Kadowaki, Shoichi Sakaguchi, Yohei Miyamoto, Kazuaki Taguchi, Nanako Muraya, Yuki Narita, Keizo Sato, Victor Tuan Giam Chuang, Toru Maruyama, Masaki Otagiri, Sumio Hirata. Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment.
Biological & pharmaceutical bulletin.
2015; 38(3):487-92. doi:
10.1248/bpb.b14-00514. [PMID: 25757933] - Yongping Guo, Qian Jiang, Dingkun Gui, Niansong Wang. Chinese Herbal Formulas Si-Wu-Tang and Er-Miao-San Synergistically Ameliorated Hyperuricemia and Renal Impairment in Rats Induced by Adenine and Potassium Oxonate.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.
2015; 37(4):1491-502. doi:
10.1159/000438517. [PMID: 26509423] - Alison S R Kydd, Rakhi Seth, Rachelle Buchbinder, Christopher J Edwards, Claire Bombardier. Uricosuric medications for chronic gout.
The Cochrane database of systematic reviews.
2014 Nov; ?(11):CD010457. doi:
10.1002/14651858.cd010457.pub2. [PMID: 25392987] - Rakhi Seth, Alison S R Kydd, Rachelle Buchbinder, Claire Bombardier, Christopher J Edwards. Allopurinol for chronic gout.
The Cochrane database of systematic reviews.
2014 Oct; ?(10):CD006077. doi:
10.1002/14651858.cd006077.pub3. [PMID: 25314636] - Kowoon Joo, Seong-Ryul Kwon, Mie-Jin Lim, Kyong-Hee Jung, Hoyeon Joo, Won Park. Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
Journal of Korean medical science.
2014 May; 29(5):657-61. doi:
10.3346/jkms.2014.29.5.657. [PMID: 24851021] - Yashaar Chaichian, Saima Chohan, Michael A Becker. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
Rheumatic diseases clinics of North America.
2014 May; 40(2):357-74. doi:
10.1016/j.rdc.2014.01.012. [PMID: 24703352] - Yuh-Ing Chen, Chi-Shen Huang. New approach to assess bioequivalence parameters using generalized gamma mixed-effect model (model-based asymptotic bioequivalence test).
Statistics in medicine.
2014 Feb; 33(5):786-97. doi:
10.1002/sim.5978. [PMID: 24105871] - Michitaka Maekawa, Hidetaka Tomida, Takafumi Aoki, Manabu Hishida, Takatoshi Morinaga, Hirofumi Tamai. Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure.
Internal medicine (Tokyo, Japan).
2014; 53(6):609-12. doi:
10.2169/internalmedicine.53.0698. [PMID: 24633032] - Frida Gustafsson, Alison J Foster, Sunil Sarda, Matthew H Bridgland-Taylor, J Gerry Kenna. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.
Toxicological sciences : an official journal of the Society of Toxicology.
2014 Jan; 137(1):189-211. doi:
10.1093/toxsci/kft223. [PMID: 24085192] - Hirokazu Wakuda, Shinya Uchida, Masahiko Ikeda, Masaki Tabuchi, Yasumitsu Akahoshi, Kazumasa Shinozuka, Shizuo Yamada. Is hyperuricemia a risk factor for arteriosclerosis? Uric acid and arteriosclerosis in apolipoprotein e-deficient mice.
Biological & pharmaceutical bulletin.
2014; 37(12):1866-71. doi:
10.1248/bpb.b14-00201. [PMID: 25451835] - Hai-yan Cai, Ting Wang, Jian-chun Zhao, Peng Sun, Gui-rui Yan, Hai-peng Ding, Ying-xia Li, He-yao Wang, Wei-liang Zhu, Kai-xian Chen. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.
Acta pharmacologica Sinica.
2013 Nov; 34(11):1397-402. doi:
10.1038/aps.2013.97. [PMID: 24077632] - Federico Colombo, Hugo Poirier, Nathalie Rioux, Maria Arias Montecillo, Jianmin Duan, Maria D Ribadeneira. A membrane vesicle-based assay to enable prediction of human biliary excretion.
Xenobiotica; the fate of foreign compounds in biological systems.
2013 Oct; 43(10):915-9. doi:
10.3109/00498254.2013.769649. [PMID: 23402371] - Guang-Liang Chen, Li-Ran Zhu, Sha Na, Li Li. [Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
2013 Jul; 38(14):2348-53. doi:
NULL. [PMID: 24199570] - Takeo Nakanishi, Kouhei Ohya, Sho Shimada, Naohiko Anzai, Ikumi Tamai. Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2013 Mar; 28(3):603-11. doi:
10.1093/ndt/gfs574. [PMID: 23291366] - Haiqing Wu, Ying Peng, Shaojie Wang, Kai Wang, Xunchen Zhao, Fan Jiang. Metabolism studies of benzbromarone in rats by high performance liquid chromatography-quadrupole time of flight mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2012 Dec; 911(?):122-32. doi:
10.1016/j.jchromb.2012.10.035. [PMID: 23217315] - Krisztina Herédi-Szabó, Emese Kis, Peter Krajcsi. The vesicular transport assay: validated in vitro methods to study drug-mediated inhibition of canalicular efflux transporters ABCB11/BSEP and ABCC2/MRP2.
Current protocols in toxicology.
2012 Nov; Chapter 23(?):Unit 23.4. doi:
10.1002/0471140856.tx2304s54. [PMID: 23169269] - Wenjing Zhu, Mingqun Pang, Liuyi Dong, Xueying Huang, Shuangmiao Wang, Lanlan Zhou. Anti-inflammatory and immunomodulatory effects of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on uric acid nephropathy rats.
Life sciences.
2012 Oct; 91(11-12):369-376. doi:
10.1016/j.lfs.2012.08.013. [PMID: 22910180] - Xia-Yi Xiao, Yi-Fei Wang, Rong Xu. [Stage-based treatment of integrative medicine on the quality of life in patients with gout].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2012 May; 32(5):620-3. doi:
". [PMID: 22679721] - Erick Prado de Oliveira, Roberto Carlos Burini. High plasma uric acid concentration: causes and consequences.
Diabetology & metabolic syndrome.
2012 Apr; 4(?):12. doi:
10.1186/1758-5996-4-12. [PMID: 22475652] - Lisa K Stamp, Peter T Chapman. Gout and organ transplantation.
Current rheumatology reports.
2012 Apr; 14(2):165-72. doi:
10.1007/s11926-012-0235-9. [PMID: 22258500] - Masafumi Kurajoh, Hidenori Koyama, Takuhito Shoji, Chihiro Sumida, Asako Yamamoto, Zenta Tsutsumi, Yuji Moriwaki, Tetsuya Yamamoto, Masafumi Koga. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
International journal of clinical pharmacology and therapeutics.
2012 Apr; 50(4):265-71. doi:
10.5414/cp201582. [PMID: 22456297] - Robert L Jackson, Barbara Hunt, Patricia A MacDonald. The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.
BMC geriatrics.
2012 Mar; 12(?):11. doi:
10.1186/1471-2318-12-11. [PMID: 22436129] - Federico Colombo, Catherine Armstrong, Jianmin Duan, Nathalie Rioux. A high throughput in vitro mrp2 assay to predict in vivo biliary excretion.
Xenobiotica; the fate of foreign compounds in biological systems.
2012 Feb; 42(2):157-63. doi:
10.3109/00498254.2011.614021. [PMID: 21961530] - Atsushi Hosomi, Takeo Nakanishi, Takuya Fujita, Ikumi Tamai. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
PloS one.
2012; 7(2):e30456. doi:
10.1371/journal.pone.0030456. [PMID: 22348008] - Fernanda Cristina Mazali, Richard J Johnson, Marilda Mazzali. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
Nephron. Experimental nephrology.
2012; 120(1):e12-9. doi:
10.1159/000330274. [PMID: 22126908] - S Fujimori, K Ooyama, H Ooyama, H Moromizato. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Nucleosides, nucleotides & nucleic acids.
2011 Dec; 30(12):1035-8. doi:
10.1080/15257770.2011.622732. [PMID: 22132953] - Yasuo Kohjimoto, Yumiko Sasaki, Isao Hara. [Clinical strategies for prevention of drug-induced urinary calculi].
Clinical calcium.
2011 Oct; 21(10):1457-63. doi:
clica111014571463. [PMID: 21960230] - Xian-xian Zhang, Wei-feng Sun, Wei Xu. [Assessment on the clinical efficacy and safety of xiezhuo chubi recipe in treating hyperuricemia].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.
2011 Sep; 31(9):1216-9. doi:
". [PMID: 22013799] - Lisa K Stamp, Sarah Jordan. The challenges of gout management in the elderly.
Drugs & aging.
2011 Aug; 28(8):591-603. doi:
10.2165/11592750-000000000-00000. [PMID: 21812496] - Izaya Nakaya, Tamehachi Namikoshi, Yuki Tsuruta, Takeshi Nakata, Yugo Shibagaki, Yoshihiro Onishi, Shunichi Fukuhara. Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey.
Nephrology (Carlton, Vic.).
2011 Jul; 16(5):518-21. doi:
10.1111/j.1440-1797.2011.01446.x. [PMID: 21303423] - Hans-Joachim Anders, Volker Vielhauer. Renal co-morbidity in patients with rheumatic diseases.
Arthritis research & therapy.
2011 Jun; 13(3):222. doi:
10.1186/ar3256. [PMID: 21722341] - Masanobu Sato, Tomohiko Wakayama, Hideaki Mamada, Yoshiyuki Shirasaka, Takeo Nakanishi, Ikumi Tamai. Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.
Biochimica et biophysica acta.
2011 Jun; 1808(6):1441-7. doi:
10.1016/j.bbamem.2010.11.002. [PMID: 21074513] - Daisaku Miura, Naohiko Anzai, Promsuk Jutabha, Suparat Chanluang, Xin He, Toshiyuki Fukutomi, Hitoshi Endou. Human urate transporter 1 (hURAT1) mediates the transport of orotate.
The journal of physiological sciences : JPS.
2011 May; 61(3):253-7. doi:
10.1007/s12576-011-0136-0. [PMID: 21350910] - Michael F Wempe, Promsuk Jutabha, Bettina Quade, Timothy J Iwen, Morin M Frick, Ian R Ross, Peter J Rice, Naohiko Anzai, Hitoshi Endou. Developing potent human uric acid transporter 1 (hURAT1) inhibitors.
Journal of medicinal chemistry.
2011 Apr; 54(8):2701-13. doi:
10.1021/jm1015022. [PMID: 21449597] - C Okuda, H Koyama, Z Tsutsumi, A Yamamoto, M Kurajoh, Y Moriwaki, T Yamamoto. Serum CRP in patients with gout and effects of benzbromarone.
International journal of clinical pharmacology and therapeutics.
2011 Mar; 49(3):191-7. doi:
10.5414/cp201425. [PMID: 21329621] - Ho Jung Shin, Michio Takeda, Atsushi Enomoto, Masaaki Fujimura, Hiroki Miyazaki, Naohiko Anzai, Hitoshi Endou. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
Nephrology (Carlton, Vic.).
2011 Feb; 16(2):156-62. doi:
10.1111/j.1440-1797.2010.01368.x. [PMID: 21272127] - Anne-Kathrin Tausche, Carsten Wunderlich, Martin Aringer. Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.
Case reports in medicine.
2011; 2011(?):397646. doi:
10.1155/2011/397646. [PMID: 21629805]